Olaplex (NASDAQ:OLPX) Issues Quarterly Earnings Results

Olaplex (NASDAQ:OLPX) announced its earnings results on Thursday. The company reported $0.01 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.01, FiscalAI reports. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. The company had revenue of $105.12 million during the quarter, compared to the consensus estimate of $104.21 million. During the same period in the previous year, the firm posted $0.01 earnings per share. The company’s revenue was up 4.4% on a year-over-year basis.

Here are the key takeaways from Olaplex’s conference call:

• FY2025 results stabilized with net sales flat at $423.0M, Q4 up 4.3%, adjusted EBITDA margin of 22.2%, positive operating cash flow of $58.7M and a cash balance of $318.7M, signaling improved financial stability.
• Management completed a global brand relaunch and 360° marketing engine that lifted awareness (+7%) and earned media (+14%), re‑engaged professionals via the Market Blitz (mid‑teens sell‑through lift) and introduced Nº.3PLUS plus the Purvala acquisition to expand the science‑led innovation pipeline.
• 2026 guidance is cautious (net sales -2% to +3%, adjusted EBITDA 21%–22%) and the company expects Q1 sales and EBITDA to be significantly pressured due to front‑loaded marketing for Nº.3PLUS, with recovery weighted toward the second half of the year.
• Channel mix is being realigned—professional channel grew strongly (Q4 +18.9%) while specialty retail declined (Q4 -14.5%), DTC grew modestly and new channels (e.g., TikTok Shop) were piloted, reflecting a strategic shift that may take time to normalize.

Olaplex Trading Down 8.2%

NASDAQ OLPX traded down $0.12 during trading hours on Friday, hitting $1.35. The company’s stock had a trading volume of 1,678,403 shares, compared to its average volume of 1,400,420. Olaplex has a twelve month low of $0.99 and a twelve month high of $1.84. The firm has a market capitalization of $897.80 million, a P/E ratio of -134.50 and a beta of 2.24. The company has a quick ratio of 3.52, a current ratio of 4.16 and a debt-to-equity ratio of 0.40. The stock has a fifty day moving average of $1.55 and a 200 day moving average of $1.36.

Analyst Ratings Changes

OLPX has been the subject of a number of research reports. Weiss Ratings reissued a “sell (d)” rating on shares of Olaplex in a report on Thursday, January 22nd. Telsey Advisory Group reiterated a “market perform” rating and issued a $2.00 price objective on shares of Olaplex in a research report on Monday, March 2nd. Jefferies Financial Group reissued a “buy” rating on shares of Olaplex in a research note on Wednesday. Wall Street Zen upgraded Olaplex from a “sell” rating to a “hold” rating in a research report on Saturday. Finally, Barclays set a $1.75 price target on Olaplex in a research note on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $1.96.

More Olaplex News

Here are the key news stories impacting Olaplex this week:

• Positive Sentiment: Q4 results showed revenue and EPS roughly in line with or slightly above expectations (revenue of $105.1M, EPS $0.01, revenue +4.4% YoY), which supports the view that core sales are stabilizing. OLAPLEX Reports Fourth Quarter and Fiscal Year 2025 Results
• Neutral Sentiment: Company materials — including the slide deck and earnings call transcript — are available for investors who want management’s detailed commentary on channel mix, marketing spend and strategic initiatives. These documents may clarify execution plans but have not yet convinced the market. Earnings Slide Deck / Press Release
• Neutral Sentiment: Several published call transcripts and recaps provide additional color on product innovation and transformation initiatives management emphasized; these are useful for judging whether spend will drive re-acceleration. Q4 2025 Earnings Call Transcript
• Negative Sentiment: FY2026 guidance came in muted: the revenue range ($414M–$435M) sits against Street expectations near $430M, leaving limited upside and triggering investor concern about growth re-acceleration. That weak forward guide is the main reason for the sharp share decline. Olaplex slides more than 20% on guidance concerns
• Negative Sentiment: Analyst/competitive write-ups flag that growth remains uneven across channels and that heavy marketing spend has yet to produce sustained acceleration — some analysts now view the turnaround as lagging and see downside risk to the current share price. Olaplex: The Turnaround Is Lagging
• Negative Sentiment: Market reaction has been strong; commentary and modeling from outlets note potential downside if management cannot reaccelerate revenue and margin progress given the company’s elevated marketing spend. Short-term momentum looks negative until guidance is proven conservative. OLPX Q4 deep dive: Transformation and innovation take center stage amidst muted guidance

Institutional Trading of Olaplex

Several institutional investors and hedge funds have recently made changes to their positions in OLPX. Empowered Funds LLC bought a new position in shares of Olaplex in the 1st quarter worth $576,000. Jane Street Group LLC increased its holdings in Olaplex by 151.8% in the first quarter. Jane Street Group LLC now owns 88,321 shares of the company’s stock valued at $112,000 after purchasing an additional 258,873 shares during the last quarter. Creative Planning lifted its stake in Olaplex by 35.0% in the second quarter. Creative Planning now owns 37,357 shares of the company’s stock valued at $52,000 after buying an additional 9,690 shares during the period. Norges Bank acquired a new position in Olaplex in the second quarter valued at about $105,000. Finally, Marshall Wace LLP boosted its holdings in Olaplex by 121.4% during the second quarter. Marshall Wace LLP now owns 346,347 shares of the company’s stock worth $485,000 after buying an additional 189,947 shares during the last quarter. Institutional investors own 87.37% of the company’s stock.

About Olaplex

Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.